Treatment of invasive streptococcal infection with a peptide derived from human high-molecular-weight kininogen

Blood

Volumn 114, Issue 2, 2009, Pages 444-451

  Oehmcke, Sonja ^a   Shannon, Oonagh ^a   Von Köckritz Blickwede, Maren ^b   Mörgelin, Matthias ^a   Linder, Adam ^a   Olin, Anders I ^a   Björck, Lars ^a   Herwald, Heiko ^a  

^a LUND UNIVERSITY   (Sweden)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; APROTININ; CLINDAMYCIN; GLYCYLCYSTEINYLPROLYLARGINYLASPARTYLISOLEUCYLPROLYLTHREONYLASPARAGINYLSERYLPROLYLGLUTAMYLLEUCYLGLUTAMYLGLUTAMYLTHREONYLLEUCYLTHREONYLHISTIDYLTHREONYLISOLEUCYLTHREONYLLYSYLLEUCYLASPARAGINYLALANYLGLUTAMYLASPARAGININE; HIGH MOLECULAR WEIGHT KININOGEN; HISTIDYLLYSYLHISTIDYLGLYCYLHISTIDYLGLYCYLHISTIDYLGLYCYLLYSYLHISTIDYLLYSYLASPARAGINYLLYSYLGLYCYLLYSYLLYSYLASPARAGINYLGLYCYLLYSYLHISTIDINE; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BLOODSTREAM INFECTION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG LESION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TISSUE INJURY; ANIMAL; BACTERIUM ADHERENCE; BAGG ALBINO MOUSE; LUNG DISEASE; PATHOLOGY; SCANNING ELECTRON MICROSCOPY; SURVIVAL RATE;

ANIMALS; BACTERIAL ADHESION; FEMALE; HUMANS; KININOGEN, HIGH-MOLECULAR-WEIGHT; LUNG DISEASES; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; PEPTIDE FRAGMENTS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SURVIVAL RATE;

EID: 67651113977     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-10-182527     Document Type: Article

References (42)

1. Cunningham MW. Pathogenesis of group A strep-tococcal infections. Clin Microbiol Rev. 2000;13: 470-511.
2. Pixley RA, Zellis S, Bankes P, et al. Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome. Crit Care Med. 1995;23:41-51.
3. Ben Nasr A, Herwald H, Sjöbring U, Renné T, Müller-Esterl W, Björck L. Absorption of kininogen from human plasma by Streptococcus pyogenes is followed by the release of bradykinin. Biochem J. 1997;326:657-660. (Pubitemid 27438036)
4. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev. 1992;44:1-80.
5. Colman RW. The contact system and sepsis. Prog Clin Biol Res. 1994;388:195-214.
6. Colman RW, Schmaier AH. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood. 1997;90:3819-3843.
7. Frick IM, Akesson P, Herwald H, et al. The contact system: a novel branch of innate immunity generating antibacterial peptides. EMBO J. 2006; 25:5569-5578. (Pubitemid 44847197)
8. Herwald H, Mörgelin M, Olsen A, et al. Activation of the contact-phase system on bacterial surfaces: a clue to serious complications in infectious diseases. Nat Med. 1998;4:298-302. (Pubitemid 28144087)
9. Persson K, Mörgelin M, Lindbom L, Alm P, Björck L, Herwald H. Severe lung lesions caused by Salmonella are prevented by inhibition of the contact system. J Exp Med. 2000;192:1415-1424. (Pubitemid 30953880)
10. Pixley RA, De La Cadena R, Page JD, et al. The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia: in vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J Clin Invest. 1993;91:61-68. (Pubitemid 23037253)
11. Pixley RA, DeLa Cadena RA, Page JD, et al. Activation of the contact system in lethal hypotensive bacteremia in a baboon model. Am J Pathol. 1992;140:897-906.
12. Sriskandan S, Kemball-Cook G, Moyes D, Canvin J, Tuddenham E, Cohen J. Contact activation in shock caused by invasive group A Streptococcus pyogenes. Crit Care Med. 2000;28:3684-3691.
13. von Köckritz-Blickwede M, Rohde M, Oehmcke S, et al. Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model. Am J Pathol. 2008;173:1657-1668.
14. Hasan AA, Cines DB, Herwald H, Schmaier AH, Müller-Esterl W. Mapping the cell binding site on high molecular weight kininogen domain 5. J Biol Chem. 1995;270:19256-19261.
15. Herwald H, Hasan AA, Godovac-Zimmermann J, Schmaier AH, Müller-Esterl W. Identification of an endothelial cell binding site on kininogen domain D3. J Biol Chem. 1995;270:14634-14642.
16. Neville DM Jr. Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system. J Biol Chem. 1971;246:6328-6334.
17. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350-4354. (Pubitemid 9256559)
18. Nesbitt SA, Horton MA. A nonradioactive biochemical characterization of membrane proteins using enhanced chemiluminescence. Anal Biochem. 1992;206:267-272.
19. Shannon O, Hertzen E, Norrby-Teglund A, Morgelin M, Sjöbring U, Björck L. Severe streptococcal infection is associated with M protein-induced platelet activation and thrombus formation. Mol Microbiol. 2007;65:1147-1157. (Pubitemid 47262818)
20. Herwald H, Mörgelin M, Dåhlbäck B, Björck L. Interactions between surface proteins of Streptococcus pyogenes and coagulation factors modulate clotting of human plasma. J Thromb Haemost. 2003;1:284-291.
21. Oehmcke S, Mörgelin M, Herwald H. Activation of the human contact system on neutrophil extracellular traps. J Innate Immun. 2009;225-230.
22. Herwald H, Mörgelin M, Svensson HG, Sjöbring U. Zinc-dependent conformational changes in domain D5 of high molecular mass kininogen modulate contact activation. Eur J Biochem. 2001;268:396-404. (Pubitemid 32862671)
23. Ben Nasr AB, Herwald H, Müller-Esterl W, Björck L. Human kininogens interact with M protein, a bacterial surface protein and virulence determinant. Biochem J. 1995;305:173-180.
24. Mattsson E, Herwald H, Cramer H, Persson K, Sjöbring U, Björck L. Staphylococcus aureus induces release of bradykinin in human plasma. Infect Immun. 2001;69:3877-3882. (Pubitemid 32493308)
25. Chavakis T, Kanse SM, Pixley RA, et al. Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen. FASEB J. 2001;15:2365-2376. (Pubitemid 33063165)
26. Nakazawa Y, Joseph K, Kaplan AP. Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5. Int Immunopharmacol. 2002;2:1875-1885. (Pubitemid 35373929)
27. Furuto-Kato S, Matsumoto A, Kitamura N, Nakanishi S. Primary structures of the mRNAs encoding the rat precursors for bradykinin and T-kinin: structural relationship of kininogens with major acute phase protein and alpha 1-cysteine proteinase inhibitor. J Biol Chem. 1985;260: 12054-12059. (Pubitemid 16228364)
28. Björck L, Åkesson P, Bohus M, et al. Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor. Nature. 1989;337:385-386. (Pubitemid 19043503)
29. Nordahl EA, Rydengård V, Mörgelin M, Schmidtchen A. Domain 5 of high molecular weight kininogen is antibacterial. J Biol Chem. 2005;280:34832-34839. (Pubitemid 41504617)
30. Conlan JW, North RJ. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J Exp Med. 1994;179:259-268. (Pubitemid 24012991)
31. Herwald H, Cramer H, Mörgelin M, et al. M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell. 2004;116:367-379. (Pubitemid 38366314)
32. Mason JW, Kleeberg U, Dolan P, Colman RW. Plasma kallikrein and Hageman factor in Gram-negative bacteremia. Ann Intern Med. 1970;73: 545-551.
33. Frick IM, Björck L, Herwald H. The dual role of the contact system in bacterial infectious disease. Thromb Haemost. 2007;98:497-502. (Pubitemid 47412875)
34. Pixley RA, Colman RW. The kallikrein-kinin system in sepsis syndrome. In: Farmer SG, ed. Handbook of Immunopharmacology: The Kinin System. San Diego, CA: Academic Press; 1997: 173-186.
35. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685-694. (Pubitemid 41505357)
36. Barnham M, Weightman N, Anderson A, Pagan F, Chapman S. Review of 17 cases of pneumonia caused by Streptococcus pyogenes. Eur J Clin Microbiol Infect Dis. 1999;18:506-509.
37. Montgomery VL, Bratcher D. Complications associated with severe invasive streptococcal syndrome. J Pediatr. 1996;129:602-604. (Pubitemid 27490799)
38. Ooe K, Nakada H, Udagawa H, Shimizu Y. Severe pulmonary hemorrhage in patients with serious group A streptococcal infections: report of two cases. Clin Infect Dis. 1999;28:1317-1319. (Pubitemid 29272812)
39. Soehnlein O, Oehmcke S, Ma X, et al. Neutrophil degranulation mediates severe lung damage triggered by streptococcal M1 protein. Eur Respir J. 2008;32:405-412.
40. Persson K, Mörgelin M, Lindbom L, Alm P, Björck L, Herwald H. Severe lung lesions caused by Salmonella are prevented by inhibition of the contact system. J Exp Med. 2000;192:1415-1424. (Pubitemid 30953880)
41. Ghebrehiwet B, Randazzo BP, Dunn JT, Silverberg M, Kaplan AP. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment. J Clin Invest. 1983;71: 1450-1456.
42. Tans G, Janssen-Claessen T, Rosing J, Griffin JH. Studies on the effect of serine protease inhibitors on activated contact factors: application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa. Eur J Biochem. 1987;164: 637-642. (Pubitemid 17075807)